How much is Magenta Medical worth in 2026?

Magenta Medical has a current valuation of N/A based on their Secondary Transaction - Private round and secondary market data.

How much funding has Magenta Medical raised?

Magenta Medical has raised $227.0M in total funding across 1 funding rounds.

Magenta Medical

Therapeutic DevicesWebsite

Magenta Medical valuation and funding history | Last updated: July 15, 2024 | 1 funding rounds

Current Valuation

N/A

As of July 15, 2024

Total Funding Raised

$227.0M

Across 1 round

Last Round

Secondary Transaction - Private

$105.0M

Last Funding

Jul 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
July 15, 2024	Later Stage VC (Series E)	$105.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Magenta Medical is currently valued at N/A as of July 15, 2024. The company has raised a total of $227.0M in funding across 1 funding round.

Track Magenta Medical Valuation Updates

Get notified when Magenta Medical raises new funding or valuation changes

Explore More Data

Detailed analysis for Magenta Medical

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Magenta Medical's valuation history, funding rounds, and growth metrics.

No credit card required

What is Magenta Medical Worth in 2026?

Magenta Medical is a leading private company in the Therapeutic Devices sector. Track Magenta Medical's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Magenta Medical Valuation is Determined

Private company valuations like Magenta Medical's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.